Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by scarlet1967on Apr 06, 2021 8:33am
93 Views
Post# 32940276

Both drugs on Find-A-Code

Both drugs on Find-A-Code

 

Both drugs are on this website thus much more practical for physicians to prescribe them.

“Find-A-Code is a product of innoviHealth Systems, Inc.  FindACode.com is an online database of medical billing codes and information. People use Find-A-Code to assign codes to medical diagnosis and procedures in order to be reimbursed by insurance companies and Medicare. FindACode.com is a quick and easy system that uses a simple search to return accurate information. Rather than searching through 10 or more books, Find-A-Code has combined the information into one simple search.

Find-A-Code's simple, search-engine-like system of searching for billing codes is very easy to use and intuitive. Find-A-Code has many tools to assist medical coders in their efforts to accurately determine proper codes for documenting medical diagnosis and procedures for claim forms, documentation, and notes.

The Find-A-Code service is available in subscription format where subscribers can choose to purchase access to FindACode.com on a monthly or annual basis. Plus Find-A-Code offers several other products (CPT Assistant, Hospital/Facility Tools, etc.) that may be added to the subscription for either a one time, monthly, or annual amount. Each of these tools is seamlessly integrated into the Find-A-Code website saving our subscribers the time and frustration it takes to search through multiple books and/or websites. You can find it ALL at FindACode.com!”

 

NDC 62064-0241 EGRIFTA SV

 

NDC 62064-0122 TROGARZO


<< Previous
Bullboard Posts
Next >>